BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu LR, Ni WJ, Cai M, Dai WT, Zhou H. Advances in RNA Epigenetic Modifications in Hepatocellular Carcinoma and Potential Targeted Intervention Strategies. Front Cell Dev Biol 2021;9:777007. [PMID: 34778277 DOI: 10.3389/fcell.2021.777007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu L, Li S, Zheng W, Ni W, Cai M, Liu H. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1086078] [Reference Citation Analysis]
2 Zhou R, Ni W, Qin C, Zhou Y, Li Y, Huo J, Bian L, Zhou A, Li J. A functional loop between YTH domain family protein YTHDF3 mediated m(6)A modification and phosphofructokinase PFKL in glycolysis of hepatocellular carcinoma. J Exp Clin Cancer Res 2022;41:334. [PMID: 36471428 DOI: 10.1186/s13046-022-02538-4] [Reference Citation Analysis]
3 Carneiro TJ, Vojtek M, Gonçalves-Monteiro S, Batista de Carvalho ALM, Marques MPM, Diniz C, Gil AM. Effect of Pd(2)Spermine on Mice Brain-Liver Axis Metabolism Assessed by NMR Metabolomics. Int J Mol Sci 2022;23. [PMID: 36430252 DOI: 10.3390/ijms232213773] [Reference Citation Analysis]
4 Du S, Guo Y, Huang J, Xu J, Chen G, Elmouki I. The Expressions and Functions of lncRNA Related to m6A in Hepatocellular Carcinoma from a Bioinformatics Analysis. Computational and Mathematical Methods in Medicine 2022;2022:1-11. [DOI: 10.1155/2022/1395557] [Reference Citation Analysis]
5 Hu J, Yang L, Peng X, Mao M, Liu X, Song J, Li H, Chen F. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma. Hum Cell 2022. [PMID: 36087219 DOI: 10.1007/s13577-022-00769-3] [Reference Citation Analysis]
6 Chen J, Yao S, Sun Z, Wang Y, Yue J, Cui Y, Yu C, Xu H, Li L. The pattern of expression and prognostic value of key regulators for m7G RNA methylation in hepatocellular carcinoma. Front Genet 2022;13:894325. [DOI: 10.3389/fgene.2022.894325] [Reference Citation Analysis]